Skip to main content
!
Phase III+: The University is open for expanded research operations; only authorized personnel will be admitted on campus. More info here.

Why male mosquitoes leave humans alone

Unlike their female counterparts, male mosquitoes have no desire to bite us. But the hardware for host-seeking is hidden in the male mosquito brain, locked behind a simple genetic switch. 

This fish is about to flip 

An elaborate set of zebrafish experiments is shining light on one of neuroscience’s greatest enigmas: How brains make decisions. By tracking neural activity, scientists can now predict a fish’s next move before it happens.

Rockefeller grants commercial license for the development of monoclonal antibodies for treatment of COVID-19

The treatment, a combination of two antibodies, has been shown highly capable of neutralizing SARS-CoV-2 in preclinical studies. Researchers hope it will give countries around the world, including developing countries, a way to control the rampant disease.

COVID-19 vaccines may need regular updates for emerging variants

Lab experiments suggest that the new strains reported in Britain, South Africa, and Brazil may blunt the potency of the Pfizer and Moderna COVID-19 vaccines. This could mean that the vaccines will need updates as the virus mutates.

Neurophysiologist Victor Wilson, 92, has died

Victor Wilson, a neurophysiologist who traced the intricate neural mechanisms that govern our balance and posture, died on January 20 at the age of 92.

Synthetic “micro lungs” could take COVID-19 research to the next level

Scientists have developed stem-cell technology to mass-produce tissue cultures resembling our breathing organs. These tissues offer a powerful model in which to study how SARS-CoV-2 wreaks havoc in the lungs and to screen for new drugs.

The immune system mounts a lasting defense after recovery from COVID-19

The study participants continued to improve their antibodies months after initial infection, potentially due to exposure to remnants of the virus hidden in the gut.

The blood may hold clues to some of COVID-19’s most mysterious symptoms

COVID-19 causes a host of diverse complications, from lung inflammation to blood clots, heart failure, and brain fog. A team of scientists believes these attributes may have a single culprit—and that findings from research on Alzheimer’s disease might give them a leg up in finding it.

Rockefeller begins testing of new COVID-19 antibody drug in people

Patients in the clinical trial will receive two highly potent antibodies against SARS-CoV-2 discovered at the university. Designed to prevent people with early COVID-19 from developing severe disease, the treatment is urgently needed as hospitals continue to be inundated by repeated surges of infection, and mass vaccinations are still months away.

What Darwin never guessed 

Scientists have found that evolution isn’t always a one-way street toward specialization.

Recent Awards and Honors

Josefina del Mármol and Shiri Gur-Cohen receive Tri-Institutional Breakout Awards

June 3, 2021

del Mármol, from Vanessa Ruta’s lab, and Gur-Cohen, from Elaine Fuchs’s lab, are recognized for their respective postdoctoral work.

Katya Vinogradova

Ekaterina V. Vinogradova named a Searle Scholar

May 20, 2021

Vinogradova receives the honor for her work designing chemical probes to dissect and alter immune protein function.

More awards and honors

Rockefeller in the News

The New York Times

“People who were infected and get vaccinated really have a terrific response, a terrific set of antibodies, because they continue to evolve their antibodies,” Dr. Nussenzweig said. “I expect that they will last for a long time.”

STAT News

“Depending potentially on the vaccination protocol, the vaccines are good enough to deal” with B.1.351 and other variants, said virologist Theodora Hatziioannou of Rockefeller University, an author of the study. “At least,” she added, “the variants we’ve seen up to now.” 

NPR

"People thought these genes were missing in birds and platypus, right? But they weren't missing. They just weren't sequenced with the older technologies," says Erich Jarvis.  

Seek magazine

Rockefeller’s flagship publication is interested not just in scientific results, but in the people, ideas, and conversations that ignite discovery. The latest issue takes us inside the response to the pandemic, where scientists are using every tool in the 21st century playbook to transform COVID-19 into a manageable disease. Also: Mosquito menace, The brain inside your gut, and Addiction then and now.


From this issue

 


Subscribe to Rockefeller Science News

Did you know Rockefeller has a monthly science newsletter? Subscribe now to stay on top of the latest discoveries, news updates, and science highlights from Rockefeller’s laboratories and researchers.